If you're having trouble viewing this email, see it on the Web.
Technet21

Home | Invite Others | Digest Archives  

Posts:

technet21 postspacerRequest for Proposal: TechNet21 Forum and Website Management

technet21 postspacerNew Bivalent Polio Vaccine Simplifies Logistics in Hard-To-Reach Areas

technet21 postspacerJapan's Support for Strengthening Cold Chain and Logistics Systems

technet21 postspacerCold Chain and Logistics Taskforce Focuses on Interagency Cooperation

technet21 postspacerPartners Begin Effort to Envision Future Supply Chain Systems

technet21 postspacerAVI Initiative Confronts Supply Chain Shortcomings

technet21 postspacerTunisia to Demonstrate Innovative Supply Chain Solutions for the Future

technet21 postspacerStable Vaccines at Tropical Temperatures

Issue 44, 1 March 2010

 
Editorial Note

Highlights of this issue include a proposal request from WHO for TechNet21, followed by the Optimize posts. Further, Michel Zaffran responds to the contribution on sugar galssification technology, placing things in perspective.


The World Health Organization (WHO) is soliciting requests for proposals for the ongoing management of the TechNet21 electronic forum and website.

... the successful bidder must demonstrate website design expertise, an understanding of the role of TechNet21 as well as a sense of its future potential. Previous experience in creating and moderating web forums and/or other social networking sites would be an asset.

[Read more]

Comment on this post by email or on the web


by Ian Lewis, UNICEF Supply Division

Since 2005, the Global Polio Eradication Initiative (GPEI) has increasingly used monovalent oral polio vaccines (OPVs) in the fight against the two wild poliovirus strains still in circulation (wild poliovirus types 1 and 3 [WPV1 and WPV3]). These vaccines have up to three times the efficacy of the traditionally used trivalent OPV... .

To complement the large-scale use of monovalent OPVs, a new bivalent OPV has now been developed. This new vaccine is poised to accelerate progress towards a polio-free world as it simultaneously targets both WPV1 and WPV3 in one dose, ....

[Read more]

Comment on this post by email or on the web


by Terry Hart and Julian Bilous, consultants, and Osman David Mansoor, UNICEF

In 2006, the Government of Japan offered funding to the United Nations Children’s Fund (UNICEF) to help countries prevent and prepare for future influenza pandemics. Recognizing that support from cold chain and logistics (CCL) systems would be vital for any vaccine response, US$8 million of this grant was used ... to strengthen CCL systems ...

UNICEF selected two consultants to review the impact of the grant ... with a specific focus on two pieces of new technology that can help CCL system performance: the Fridge-tag and the SolarChill refrigerator.

[Read more]

Comment on this post by email or on the web


by Osman David Mansoor, UNICEF Programme Division and Ibrahim El-Zig, UNICEF Supply Division

In November 2009, the United Nations Children’s Fund (UNICEF) hosted a workshop of the Cold Chain and Logistics (CCL) Taskforce. The purpose of the workshop was to reach consensus on the approach and key actions needed to support the strengthening and expansion of CCL systems...

The CCL Taskforce created four interagency subgroups to address these challenges directly: (1) guidance, (2) monitoring, (3) advocacy, and (4) integration.

[Read more]

Comment on this post by email or on the web


by Brent Burkholder, CDC, and Ibrahim El-Zig, UNICEF Supply Division

Vision: By 2025, state-of-the-art supply systems meet the changing needs of a changing world.

Objective: To enable the right vaccines to be in the right place, at the right time, in the right quantities, in the right condition, at the right cost. Specific steps to achieve this objective are listed below:

  • Vaccine products and their packaging are designed with characteristics that best suit the operational needs of countries while ensuring that the highest standards of safety are maintained.
  • Vaccine distribution systems are streamlined for maximum efficiency and are built around mechanisms that support continuous learning to improve system performance.

[Read more]

Comment on this post by email or on the web


by Stefano Maltovi, PATH, and Souleymane Kone, WHO

The Accelerated Vaccine Introduction (AVI) initiative will see the first wave of pneumococcal vaccines entering up to 15 GAVI Alliance-approved countries in 2010. Another 11 countries are expected to follow suit in the next year. While some countries already have cold chain capacity for the new vaccine, independent assessments have revealed that some countries do not yet have capacity at all levels, and their introduction schedule could be delayed until they are ready.

[Read more]

Comment on this post by email or on the web


by Patrick Lydon and Ibrahim Abdel Rahim, WHO

A new era of immunization supply systems officially got under way on Friday, January 22, 2010, in Tunis, when the Ministry of Public Health, the World Health Organization (WHO), and Project Optimize formally signed a cooperative agreement. The three-year project, with a budget of US$1.75 million, will focus on five key intervention areas:

  1. Demonstrate the benefits of streamlining and integrating the supply chains for vaccines, drugs, and other temperature-sensitive products between national and regional levels.
  2. Demonstrate the benefits of a "Zero Energy Cost Supply Chain" below the regional level by using solar energy to generate and feed into the grid the equivalent amount of the energy required for warehousing and transportation (using electric vehicles).

[Read more]

Comment on this post by email or on the web


by Omesh Bharti

While I personally believe that any progress towards more stable vaccines is great news and takes us in a very good direction I would like to make a few comments that may give some perspective to the "discovery" announced by the Oxford University.

1) The first efforts to stabilize vaccines in sugar started in the late 1980's and early 1990's. Financial constraints and then legal fights around sugar-glassification technology IP issues have prevented these discoveries from having any substantial impact so far. ... [Michel Zaffran]

[Read more]

Comment on this post by email or on the web

Photos Courtesy: Markku Toryalai Hart Photo Courtesy: Olivier Ronveaux, WHO

 

 

Web Highlights
:
technet21 post

Polio eradication within 5 years now a real possibility

technet21 post

Gates Foundation's decade of vaccines

  technet21 post

Cape measles outbreak

  technet21 post

Making public policies on vaccination with limited information

  technet21 post

Phones, paper 'chips' may fight disease

  technet21 post

A jewel for disease tracking

  technet21 post

Bangladesh to vaccinate 20 million children against measles

  technet21 post

Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine

  technet21 post

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

 

Register

If you have contributions to make or thoughts to share with others on TechNet21, you can write to the moderator or post directly on the web forums. Click here to change your subscription settings or unsubscribe from the mailing list.

TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.

For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.